Isolation and implantation of bone marrow-derived mesenchymal stem cells with fibrin micro beads to repair a critical-size bone defect in mice

Alon Ben-Ari, Rachel Rivkin, Miryam Frishman, Elena Gaberman, Lilia Levdansky, Raphael Gorodetsky

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Fibrin microbeads (FMBs) made using thermal treatment of fibrin drops in oil can efficiently isolate mesenchymal stem cells (MSCs) from bone marrow (BM) and other similar sources and culture them continuously in suspension culture. The pure mesenchymal profile of MSCs isolated using FMBs and their differentiation potency to different mesenchymal lineages were previously described in detail. In the current study, MSCs were isolated from the BM of GFP+ C57/bl mice using FMBs. Addition of pro-osteogenic medium with 10mM of Β-glycerolphosphate, 50μg/mL of ascorbic acid, and 10 -8M of dexamethasone for 1 month resulted in ossified bone-like solid cellular structures, as seen using fluorescence and scanning electron microscopy (SEM). Such spontaneously formed structures were implanted in full-depth approximately 5-mm-diameter drilled defects in the skulls of wild-type c57/bl mice. Two months later, the excised upper parts of the skulls with the defects were viewed using fluorescence microscopy for green fluorescence protein of the cells in the defect and using SEM. They were also scanned using micro-computed tomography to visualize the formation of new hard tissue. Then the samples were processed and sectioned for hematoxylin and eosin staining and immunohistochemistry. Implanted FMBs loaded with GFP+ MSCs formed partially mature, dense bone-like tissue using a residual moderate inflammatory process containing remnants of FMBs and neo-angiogenesis. The filled defect with bone-like tissue had a Ca/P ratio similar to that of native bone. Limited merging of the implant with the skull indicated that the induced bone regeneration derived from the MSCs that were delivered with the implant. No repair was seen in the control animals without implants or where the defect was filled with FMBs only. Repair scoring (on a 0-5 scale) was found to be 3.38±0.35 in the experimental arm, relative to 0 in the controls (p<0.001).

Original languageEnglish (US)
Pages (from-to)2537-2546
Number of pages10
JournalTissue Engineering - Part A
Volume15
Issue number9
DOIs
StatePublished - Sep 1 2009
Externally publishedYes

Fingerprint

Stem cells
Fibrin
Mesenchymal Stromal Cells
Microspheres
Bone
Repair
Bone Marrow
Bone and Bones
Defects
Skull
Tissue
Electron Scanning Microscopy
Fluorescence
Glycerophosphates
Scanning electron microscopy
Bone Regeneration
Ascorbic acid
Fluorescence microscopy
Cellular Structures
Hematoxylin

ASJC Scopus subject areas

  • Bioengineering
  • Biochemistry
  • Biomedical Engineering
  • Biomaterials

Cite this

Isolation and implantation of bone marrow-derived mesenchymal stem cells with fibrin micro beads to repair a critical-size bone defect in mice. / Ben-Ari, Alon; Rivkin, Rachel; Frishman, Miryam; Gaberman, Elena; Levdansky, Lilia; Gorodetsky, Raphael.

In: Tissue Engineering - Part A, Vol. 15, No. 9, 01.09.2009, p. 2537-2546.

Research output: Contribution to journalArticle

Ben-Ari, Alon ; Rivkin, Rachel ; Frishman, Miryam ; Gaberman, Elena ; Levdansky, Lilia ; Gorodetsky, Raphael. / Isolation and implantation of bone marrow-derived mesenchymal stem cells with fibrin micro beads to repair a critical-size bone defect in mice. In: Tissue Engineering - Part A. 2009 ; Vol. 15, No. 9. pp. 2537-2546.
@article{ee8bac5ac5184a199b58bc7f146460c3,
title = "Isolation and implantation of bone marrow-derived mesenchymal stem cells with fibrin micro beads to repair a critical-size bone defect in mice",
abstract = "Fibrin microbeads (FMBs) made using thermal treatment of fibrin drops in oil can efficiently isolate mesenchymal stem cells (MSCs) from bone marrow (BM) and other similar sources and culture them continuously in suspension culture. The pure mesenchymal profile of MSCs isolated using FMBs and their differentiation potency to different mesenchymal lineages were previously described in detail. In the current study, MSCs were isolated from the BM of GFP+ C57/bl mice using FMBs. Addition of pro-osteogenic medium with 10mM of Β-glycerolphosphate, 50μg/mL of ascorbic acid, and 10 -8M of dexamethasone for 1 month resulted in ossified bone-like solid cellular structures, as seen using fluorescence and scanning electron microscopy (SEM). Such spontaneously formed structures were implanted in full-depth approximately 5-mm-diameter drilled defects in the skulls of wild-type c57/bl mice. Two months later, the excised upper parts of the skulls with the defects were viewed using fluorescence microscopy for green fluorescence protein of the cells in the defect and using SEM. They were also scanned using micro-computed tomography to visualize the formation of new hard tissue. Then the samples were processed and sectioned for hematoxylin and eosin staining and immunohistochemistry. Implanted FMBs loaded with GFP+ MSCs formed partially mature, dense bone-like tissue using a residual moderate inflammatory process containing remnants of FMBs and neo-angiogenesis. The filled defect with bone-like tissue had a Ca/P ratio similar to that of native bone. Limited merging of the implant with the skull indicated that the induced bone regeneration derived from the MSCs that were delivered with the implant. No repair was seen in the control animals without implants or where the defect was filled with FMBs only. Repair scoring (on a 0-5 scale) was found to be 3.38±0.35 in the experimental arm, relative to 0 in the controls (p<0.001).",
author = "Alon Ben-Ari and Rachel Rivkin and Miryam Frishman and Elena Gaberman and Lilia Levdansky and Raphael Gorodetsky",
year = "2009",
month = "9",
day = "1",
doi = "10.1089/ten.tea.2008.0567",
language = "English (US)",
volume = "15",
pages = "2537--2546",
journal = "Tissue Engineering - Part A",
issn = "1937-3341",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Isolation and implantation of bone marrow-derived mesenchymal stem cells with fibrin micro beads to repair a critical-size bone defect in mice

AU - Ben-Ari, Alon

AU - Rivkin, Rachel

AU - Frishman, Miryam

AU - Gaberman, Elena

AU - Levdansky, Lilia

AU - Gorodetsky, Raphael

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Fibrin microbeads (FMBs) made using thermal treatment of fibrin drops in oil can efficiently isolate mesenchymal stem cells (MSCs) from bone marrow (BM) and other similar sources and culture them continuously in suspension culture. The pure mesenchymal profile of MSCs isolated using FMBs and their differentiation potency to different mesenchymal lineages were previously described in detail. In the current study, MSCs were isolated from the BM of GFP+ C57/bl mice using FMBs. Addition of pro-osteogenic medium with 10mM of Β-glycerolphosphate, 50μg/mL of ascorbic acid, and 10 -8M of dexamethasone for 1 month resulted in ossified bone-like solid cellular structures, as seen using fluorescence and scanning electron microscopy (SEM). Such spontaneously formed structures were implanted in full-depth approximately 5-mm-diameter drilled defects in the skulls of wild-type c57/bl mice. Two months later, the excised upper parts of the skulls with the defects were viewed using fluorescence microscopy for green fluorescence protein of the cells in the defect and using SEM. They were also scanned using micro-computed tomography to visualize the formation of new hard tissue. Then the samples were processed and sectioned for hematoxylin and eosin staining and immunohistochemistry. Implanted FMBs loaded with GFP+ MSCs formed partially mature, dense bone-like tissue using a residual moderate inflammatory process containing remnants of FMBs and neo-angiogenesis. The filled defect with bone-like tissue had a Ca/P ratio similar to that of native bone. Limited merging of the implant with the skull indicated that the induced bone regeneration derived from the MSCs that were delivered with the implant. No repair was seen in the control animals without implants or where the defect was filled with FMBs only. Repair scoring (on a 0-5 scale) was found to be 3.38±0.35 in the experimental arm, relative to 0 in the controls (p<0.001).

AB - Fibrin microbeads (FMBs) made using thermal treatment of fibrin drops in oil can efficiently isolate mesenchymal stem cells (MSCs) from bone marrow (BM) and other similar sources and culture them continuously in suspension culture. The pure mesenchymal profile of MSCs isolated using FMBs and their differentiation potency to different mesenchymal lineages were previously described in detail. In the current study, MSCs were isolated from the BM of GFP+ C57/bl mice using FMBs. Addition of pro-osteogenic medium with 10mM of Β-glycerolphosphate, 50μg/mL of ascorbic acid, and 10 -8M of dexamethasone for 1 month resulted in ossified bone-like solid cellular structures, as seen using fluorescence and scanning electron microscopy (SEM). Such spontaneously formed structures were implanted in full-depth approximately 5-mm-diameter drilled defects in the skulls of wild-type c57/bl mice. Two months later, the excised upper parts of the skulls with the defects were viewed using fluorescence microscopy for green fluorescence protein of the cells in the defect and using SEM. They were also scanned using micro-computed tomography to visualize the formation of new hard tissue. Then the samples were processed and sectioned for hematoxylin and eosin staining and immunohistochemistry. Implanted FMBs loaded with GFP+ MSCs formed partially mature, dense bone-like tissue using a residual moderate inflammatory process containing remnants of FMBs and neo-angiogenesis. The filled defect with bone-like tissue had a Ca/P ratio similar to that of native bone. Limited merging of the implant with the skull indicated that the induced bone regeneration derived from the MSCs that were delivered with the implant. No repair was seen in the control animals without implants or where the defect was filled with FMBs only. Repair scoring (on a 0-5 scale) was found to be 3.38±0.35 in the experimental arm, relative to 0 in the controls (p<0.001).

UR - http://www.scopus.com/inward/record.url?scp=69249104179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249104179&partnerID=8YFLogxK

U2 - 10.1089/ten.tea.2008.0567

DO - 10.1089/ten.tea.2008.0567

M3 - Article

VL - 15

SP - 2537

EP - 2546

JO - Tissue Engineering - Part A

JF - Tissue Engineering - Part A

SN - 1937-3341

IS - 9

ER -